A detailed history of Field & Main Bank transactions in Eli Lilly & CO stock. As of the latest transaction made, Field & Main Bank holds 8,172 shares of LLY stock, worth $6.16 Million. This represents 2.61% of its overall portfolio holdings.

Number of Shares
8,172
Previous 8,145 0.33%
Holding current value
$6.16 Million
Previous $7.37 Million 1.83%
% of portfolio
2.61%
Previous 2.79%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$772.14 - $960.02 $20,847 - $25,920
27 Added 0.33%
8,172 $7.24 Million
Q2 2024

Jul 25, 2024

BUY
$724.87 - $909.04 $118,878 - $149,082
164 Added 2.05%
8,145 $7.37 Million
Q1 2024

Apr 29, 2024

BUY
$592.2 - $792.28 $153,379 - $205,200
259 Added 3.35%
7,981 $6.21 Million
Q4 2023

Feb 05, 2024

BUY
$525.19 - $619.13 $350,826 - $413,578
668 Added 9.47%
7,722 $4.5 Million
Q3 2023

Oct 12, 2023

BUY
$434.7 - $599.3 $2.13 Million - $2.94 Million
4,905 Added 228.25%
7,054 $3.79 Million
Q2 2023

Jul 26, 2023

BUY
$350.74 - $468.98 $140,296 - $187,592
400 Added 22.87%
2,149 $1.01 Million
Q1 2023

Apr 19, 2023

BUY
$310.63 - $364.82 $239,185 - $280,911
770 Added 78.65%
1,749 $600,000
Q4 2022

Jan 19, 2023

BUY
$321.55 - $374.67 $35,370 - $41,213
110 Added 12.66%
979 $0
Q3 2022

Oct 25, 2022

SELL
$296.48 - $337.87 $2,075 - $2,365
-7 Reduced 0.8%
869 $281,000
Q2 2022

Jul 18, 2022

BUY
$278.73 - $327.27 $1,951 - $2,290
7 Added 0.81%
876 $284,000
Q3 2021

Oct 14, 2021

SELL
$221.6 - $272.71 $2,216 - $2,727
-10 Reduced 1.14%
869 $201,000
Q4 2020

Feb 25, 2021

SELL
$130.46 - $172.63 $1,174 - $1,553
-9 Reduced 1.01%
879 $148,000
Q3 2018

Oct 23, 2018

SELL
$85.86 - $107.31 $3,348 - $4,185
-39 Reduced 4.21%
888 $95,000
Q2 2018

Aug 13, 2018

BUY
$75.7 - $86.88 $5,904 - $6,776
78 Added 9.19%
927 $92,000
Q4 2017

Jan 24, 2018

BUY
$81.94 - $87.89 $69,567 - $74,618
849
849 $72,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $716B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Field & Main Bank Portfolio

Follow Field & Main Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Field & Main Bank, based on Form 13F filings with the SEC.

News

Stay updated on Field & Main Bank with notifications on news.